{"uid":"cap_-geueNV2mCfWE3T0IFqkB","slug":"pocket-network-pharma-signals-fda-drug-market-safety-briefs-4ff61185","name":"Pocket Network Pharma Signals – FDA & Drug Market Safety Briefs","description":"Scored drug-market and company safety briefs from openFDA, FDA, BLS and ClinicalTrials.gov: recalls, adverse events, approvals, trial pipelines, shortages, device safety, warning letters and drug prices, for the US market and for Pfizer, Lilly and J&J. Each is a 0-100 score with drivers and citations. POST /v1/brief with {vertical}. Research signal, not medical or investment advice.","url":"https://agent.pocket.network/v1/pmic-pharma-signals?utm_source=zero.xyz","method":"POST","headers":{},"bodySchema":{"type":"object","properties":{"horizon":{"enum":["7d","30d","90d","365d"],"type":"string","description":"The window the trend is measured over."},"vertical":{"enum":["drug-market","company-safety","clinical-pipeline","drug-shortages","device-safety","drug-prices","fda-enforcement"],"type":"string","description":"Which brief to score."},"entity_id":{"enum":["pfe","lly","jnj"],"type":"string","description":"The drug maker, for the company verticals."}}},"responseSchema":null,"example":null,"exampleRequest":null,"tags":["x402"],"displayCostAmount":"0.005","displayCostAsset":"USDC","priceDynamic":false,"priceHint":null,"priceStatus":"priced","priceSource":"probe","requiresHandshake":false,"reviewCount":0,"rating":{"score":"0.00","successRate":"0.00","reviews":0,"stars":null,"state":"unrated"},"availabilityStatus":"unknown","priceObserved":null,"sessionDeposit":null,"pricing":{"kind":"static","summary":"$0.005/call","primary":{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.005","per":"call","confidence":"exact"},"accepted":[{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.005","per":"call","confidence":"exact"}]},"paymentMethods":[{"uid":"pm_QgEJab4LATvh2xEm0PsTp","protocol":"x402","methodType":"crypto","chain":"base","mode":"charge","costAmount":"0.005","costPer":"request","priority":0,"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","unit":"request","depositMicros":null,"planRef":null}],"brandName":null,"brandSlug":null,"brandBaseUrl":null,"brandDocsUrl":null,"whatItDoes":"Returns scored (0-100) safety and market intelligence briefs for US pharma verticals and specific drug makers (Pfizer, Lilly, J&J), sourced from openFDA, FDA, BLS, and ClinicalTrials.gov","exampleAgentPrompt":"Pull me a 30-day drug-market safety brief with a scored summary — including recalls, adverse events, and approvals — for the US pharma market overall.","exampleUseCases":[{"title":"Pfizer safety monitoring for investment research","prompt":"Give me a company-safety brief scored over the last 90 days for Pfizer — I want to see the score, the main drivers, and any citations around recalls or warning letters."},{"title":"US drug shortage intelligence briefing","prompt":"What's the current drug-shortages brief for the US market over the last 30 days? I need a 0-100 score and the key factors driving it."},{"title":"Lilly clinical pipeline signal for biotech analyst","prompt":"Score Lilly's clinical pipeline over the past 365 days and summarize what's in the trial pipeline from ClinicalTrials.gov, including any notable approvals or setbacks."}],"resultDescription":"A structured JSON response containing a 0-100 safety or market signal score for the requested pharma vertical or company, along with the key drivers behind the score and citations from source databases (openFDA, FDA, BLS, ClinicalTrials.gov). Coverage includes recalls, adverse events, drug approvals, clinical trial pipelines, drug shortages, device safety signals, FDA warning letters, and drug prices depending on the vertical selected.","failureModes":["Invalid or missing 'vertical' enum value returns a validation error","Unsupported 'entity_id' for non-company verticals may return an error or be ignored","Upstream FDA or ClinicalTrials.gov data unavailability may result in stale or incomplete scores","Horizon enum mismatches return a 422 validation error","Payment failure (insufficient USDC) prevents request from being processed via x402 protocol"],"whenToPreferThis":"Choose this endpoint when you need a pre-aggregated, scored signal (0-100) for pharma safety or market intelligence rather than raw FDA data. It is ideal for research workflows, investment due diligence, or regulatory monitoring that requires a synthesized view across openFDA, BLS, and ClinicalTrials.gov for specific companies (Pfizer, Lilly, J&J) or the broader US drug market. Prefer this over raw ClinicalTrials.gov or openFDA endpoints when you need citations and scoring in one call without building your own aggregation logic.","instructions":null,"reviewSummary":null,"reviewSummaryHighlights":null,"reviewSummaryConcerns":null,"reviewSummaryGeneratedAt":null,"activationCount":0,"lastUsedAt":null,"lastSuccessfullyRanAt":null,"lastHealthCheckAt":"2026-10-16T12:42:02.613Z","isFirstParty":false,"canonicalSlug":"pocket-network-pharma-signals-fda-drug-market-safety-briefs-4ff61185"}